Published in
Taylor and Francis Group, Leukemia & Lymphoma, 12(63), p. 2832-2846, 2022
DOI: 10.1080/10428194.2022.2098287
Links
Tools
Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review
Journal article published in 2022 by
Isabella R. Plumptre,
Jordan T. Said 
,
Tiffany Sun,
Cecilia Larocca,
Cesar A. Virgen,
Thomas S. Kupper,
David C. Fisher,
Philip M. Devlin,
Christopher P. Elco,
Johanna Sheu Song,
Nicole R. LeBoeuf
,
Tiffany Sun,
Cecilia Larocca,
Cesar A. Virgen,
Thomas S. Kupper,
David C. Fisher,
Philip M. Devlin,
Christopher P. Elco,
Johanna Sheu Song,
Nicole R. LeBoeuf
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 